In addition, based on clinical information acquired from TCGA and CIBERSORT results, we found that several tumor-infiltrating immune cells related to GRAMD1C expression have significant correlation with prognosis of KIRC patients, which is consistent with previous studies (Xu et al., 2013; Wang & Ke, 2011; Overacre-Delgoffe et al., 2017). The gene discussed is GRAMD1C; the disease is neoplasm.